Aevi Genomic Medicine, Inc. (21)

Browse by Contract Category

Contracts

Option Termination Agreement, effective February 3, 2020, by and between Aevi Genomic Medicine, Inc. and Garry A. Neil (Filed With SEC on February 3, 2020)
Agreement and Plan of Merger and Reorganization, dated as of December 5, 2019 among Aevi Genomic Medicine, Inc., Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and Cerecor... (Filed With SEC on December 11, 2019)
Form of Warrant Amendment Agreement of Aevi Genomic Medicine, Inc. dated December 5, 2019 (Filed With SEC on December 10, 2019)
Letter Agreement, dated November 11, 2019, by and between Aevi Genomic Medicine, Inc. and Michael McInaw (Filed With SEC on November 14, 2019)
Option and License Agreement, dated as of August 6, 2019, by and between Aevi Genomic Medicine, Inc. and MedImmune Limited (Filed With SEC on November 14, 2019)
Option Termination Agreement, effective February 3, 2020, by and between Aevi Genomic Medicine, Inc. and Michael F. Cola (Filed With SEC on February 3, 2020)
Agreement and Plan of Merger and Reorganization, dated as of December 5, 2019 among Aevi Genomic Medicine, Inc., Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and Cerecor... (Filed With SEC on December 5, 2019)
Promissory Note for Operating Expenses, dated December 5, 2019, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc (Filed With SEC on December 5, 2019)
Promissory Note for License Expenses, dated December 5, 2019, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc (Filed With SEC on December 5, 2019)
Form of Voting Agreement of Aevi Genomic Medicine, Inc. dated December 5, 2019 (Filed With SEC on December 5, 2019)
Amendment No. 4 to Sponsored Research Agreement, dated as of August 12, 2019, by and between Medgenics Medical Israel Ltd. and The Children's Hospital of Philadelphia (Filed With SEC on August 13, 2019)
Amendment No. 3 to License Agreement, dated as of August 12, 2019, by and between Medgenics Medical Israel Ltd. and The Children's Hospital of Philadelphia (Filed With SEC on August 13, 2019)
Royalty Agreement, dated as of July 19, 2019, between and among Aevi Genomic Medicine, Inc., Michael F. Cola Joseph J. Grano, Jr., Kathleen Jane Grano, Joseph C. Grano, The Grano... (Filed With SEC on August 13, 2019)
Exclusive License Agreement, dated as of July 15, 2019, by and between Aevi Genomic Medicine, Inc. and OSI Pharmaceuticals, LLC (Filed With SEC on August 13, 2019)
Letter Agreement, dated May 21, 2019, by and between Aevi Genomic Medicine, Inc. and Michael McInaw (Filed With SEC on May 21, 2019)
Security Agreement, dated March 29, 2019, by and between the Company, certain direct and indirect subsidiaries of the Company and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
Letter Agreement, dated March 29, 2019, by and between the Company and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
Amendment No. 3 to Sponsored Research Agreement, dated March 29, 2019, by and between Medgenics Medical Israel Ltd. and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
Amendment No. 2 to License Agreement, dated March 29, 2019, by and between Medgenics Medical Israel Ltd. and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
Amendment No. 1 to License Agreement, dated March 29, 2019, by and between neuroFix LLC and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)
Secured Convertible Promissory Note, dated March 29, 2019, by and between the Company and the Childrens Hospital of Philadelphia (Filed With SEC on May 14, 2019)